SQZ Biotechnologies Reports Third Quarter 2021 Financial Results and Recent Portfolio Updates

WATERTOWN, Mass.–(BUSINESS WIRE)–SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today reported third quarter 2021 financial results and recent portfolio updates.
This was another…

Click here to view the original article.